MANGALAM GLOBAL ENTERPRISE
Back to Income Statement
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,424 Cr | ₹1,279 Cr | ₹960 Cr | ₹582 Cr | ₹390 Cr |
What is the latest Revenue of MANGALAM GLOBAL ENTERPRISE ?
Year | Revenue |
---|---|
Mar2024 | ₹1,424 Cr |
Mar2023 | ₹1,279 Cr |
Mar2022 | ₹960 Cr |
Mar2021 | ₹582 Cr |
Mar2020 | ₹390 Cr |
How is Revenue of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,424 Cr | 11.36 | |
Mar2023 | ₹1,279 Cr | 33.24 | |
Mar2022 | ₹960 Cr | 64.99 | |
Mar2021 | ₹582 Cr | 49.24 | |
Mar2020 | ₹390 Cr | - |
Compare Revenue of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹485.8 Cr | -1.3% | 17.8% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,795.3 Cr | 3.2% | -1.1% | -1.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,120.2 Cr | 0.4% | -19.3% | 23.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,266.0 Cr | 0.3% | 0.3% | -16.8% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,477.4 Cr | 0.4% | 4.1% | -26% | Stock Analytics | |
INDO US BIOTECH | ₹305.6 Cr | -0.4% | -2.7% | -26.8% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | -1.3% |
17.8% |
|
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses